Clinical trialUNITERAREApr 9
Researchers are testing a new medicine called difelikefalin to see if it's safe and works well for teenagers on kidney dialysis who have severe itching. Itching is a common problem for dialysis patients that can really affect their quality of life. This study will check whether the medicine helps reduce itching and what side effects it might cause.
WHY IT MATTERSThis is the first trial testing difelikefalin specifically in adolescents on hemodialysis with moderate-to-severe pruritus — a condition that significantly impacts quality of life but has limited treatment options for younger patients.
Clinical trialUNITERAREApr 3
Researchers are testing a new drug called Xaluritamig to treat Ewing sarcoma, a rare bone cancer that has come back or stopped responding to previous treatments. This is an early-stage study (Phase 1) that will include children, teenagers, and adults. The study is now accepting patients and is expected to start in April 2026.
WHY IT MATTERSThis trial offers a potential new treatment option for patients with relapsed or refractory Ewing sarcoma, a rare pediatric cancer with limited treatment alternatives after standard therapies fail.
ResearchPUBMEDApr 1
Researchers in Brazil studied dental care for children and teens with rare diseases at five specialized centers. They found that over 1,000 young patients with 244 different rare diseases received dental treatment, with blood-related diseases being the most common. On average, kids didn't see a dentist for the first time until age 8, and many had to travel far from home to get specialized dental care.
WHY IT MATTERSThis study shows that children with rare diseases often wait years before receiving dental care and face significant travel barriers—highlighting a critical gap in specialized dental services that families should advocate for in their own communities.
ResearchPUBMEDMar 26
Researchers in China studied 26 children and young adults (average age 8 years old) who had a rare cancer called rhabdomyosarcoma that started in the female reproductive organs. They tracked these patients for an average of nearly 5 years to see how well different treatments worked. This study helps doctors understand the best ways to treat this uncommon type of cancer in girls and young women.
WHY IT MATTERSThis is the first large study from China showing long-term survival rates for girls with genital rhabdomyosarcoma, which can help doctors worldwide improve treatment plans and give families more accurate information about what to expect.
ResearchCLINICALTRIALSMar 26
Researchers in Pakistan completed a study testing whether a mindfulness program called MindUP could help orphan teenagers feel less depressed, anxious, and stressed. The program teaches techniques to calm the mind and manage difficult emotions. This study involved 61 teenagers living in orphan care institutions who often experience sadness and worry from losing their parents and living in institutional settings.
WHY IT MATTERSThis research demonstrates that mindfulness-based interventions can be effective mental health tools for vulnerable adolescent populations in resource-limited settings, potentially offering low-cost psychological support for orphaned youth.